Skip to main content
Log in

Current approach to antithrombotic therapy: An abbreviated reference for practicing clinicians

  • Frontiers in Thrombocardiology
  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Dalen JE, Hirsh J, eds. Fourth ACCP Consensus Conference on Antithrombotic Therapy. Chest 1995;108:225S–522S.

  2. Eritsland J, Arnesen H, Gronseth K, Fjeld NB, Abdelnoor M. Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass artery graft patency. Am J Cardiol 1996;77:31–36.

    Google Scholar 

  3. Schulman S, Rhedin AS, Lindmarker P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 1995;332:1661–1665.

    Google Scholar 

  4. European Atrial Fibrillation Trial Study Group. Optimal oral anticoagulant therapy in patients with non-rheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med 1995;333:5–10.

    Google Scholar 

  5. Cappelleri JC, Fiore LD, Bruphy MT, Deykin D, Lau J. Efficacy and safety of combined anticoagulant and antiplatelet therapy versus anticoagulant monotherapy after mechanical heart valve replacement: A metaanalysis. Am Heart J 1995;130:547–552.

    Google Scholar 

  6. van Bergen PF, Deckers JW, Jonker JJ, von Domburg RT, Azar AJ, Hofman A. Efficiency of long-term anticoagulation treatment in subgroups of patients after myocardial infarction. Br Heart J 1995;74:117–121.

    Google Scholar 

  7. Antman EM, for the TIMI Investigators. Heparin vs. hirudin as adjunctive therapy for thrombolysis in MI: TIMI 9. Presented at the 11th International Workshop of Thrombolysis and Interventional Therapy in Acute Myocardial Infarction, American Heart Association Scientific Sessions; Anaheim, CA, November 1995.

    Google Scholar 

  8. van der Meer J, Brutel de la Riviere A, van Gilst WH, et al. Effects of low-dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: Patency and clinical outcome at 1 year. J Am Coll Cardiol 1994;24:1181–1188.

    Google Scholar 

  9. The National Institute of Neurologic Disorders and Stroke r-tPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–1587.

    Article  PubMed  Google Scholar 

  10. Kay R, Wong KS, Yu LY, et al. Low-molecular weight heparin for the treatment of acute ischemic stroke. N Engl J Med 1995;333:1588–1593.

    Google Scholar 

  11. Brack MJ, Ray S, Chauhan A, et al. The subcutaneous heparin and angioplasty restenosis prevention (SHARP) trial. Results of a multicenter randomized trial investigating the effects of high dose unfractionated heparin on angiographic restenosis and clinical outcome. J Am Coll Cardiol 1995;26:947–954.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spencer, F., Becker, R.C. Current approach to antithrombotic therapy: An abbreviated reference for practicing clinicians. J Thromb Thrombol 3, 307–325 (1996). https://doi.org/10.1007/BF00133074

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00133074

Key Words

Navigation